The Expression of IL-6 and its Related Genes in Acute Leukemia

References

• Kishimoto T. The biology of interleukin-6. Blood 1989; 74: 1–10
   PubMed Web of Science ®Google Scholar
• Human cytokines: Handbook for basic and clinical research, B. B. Aggarwal, J. U. Gutterman. Blackwell Scientific Publications, Boston
   Google Scholar
• Kawano M., Hirano T., Mastuda T., Taga T., Horii Y., Iwato K., Asaoku H., Tang B., Tanabe O., Tanaka H., Kuramoto A., Kishimoto T. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 1988; 332: 83–85
   PubMed Web of Science ®Google Scholar
• Nilsson K., Jernberg H., Pettersson M. IL-6 as a growth factor for human multiple myeloma cells–short overview. Curr. Top. Microbiol. Immunol 1990; 166: 3–12
   PubMed Web of Science ®Google Scholar
• Zhang X-G, Klein B., Bataille R. Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma. Blood 1989; 74: 11–13
   PubMed Web of Science ®Google Scholar
• Klein B., Zhang X-G., Jourdan M., Content J., Houssiau F., Aarden L., Piechaczyk M., Bataille R. Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood 1989; 73: 517–526
   PubMed Web of Science ®Google Scholar
• Shimizu S., Yoshioka R., Hirose Y., Sugai S., Tachibana J., Honda S. Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon β2) dependent human bone marrow-derived myeloma cell lines. J. Exp. Med 1989; 169: 339–344
   PubMed Web of Science ®Google Scholar
• Yoshizaki K., Matsuda T., Nishimoto N., Kuritani T., Taeho L., Aozasa K., Nakahata T., Kawai H., Tagoh H., Komori T., Kishimoto S., Hirano T., Kishimoto T. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 1989; 74: 1360–1367
   PubMed Web of Science ®Google Scholar
• Beck J. T., Hsu S-M., Wijdenes J., Bataille R., Klein B., Vesole D., Hayden K., Jagannath S., Barlogie B. Alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. New Engl. J. Med 1994; 330: 602–605
   PubMed Web of Science ®Google Scholar
• Agematsu K., Takeuchi S., Ichikawa M., Yabuhara A., Uehara Y., Kawai H., Miyagawa Y., Ishii K., Katsuyama T., Nakahata T., Komiyama A. Spontaneous production of interleukin-6 by Ki-1-positive large-cell anaplastic lymphoma with extensive bone destruction. Blood 1991; 77: 2299–2303
   PubMed Web of Science ®Google Scholar
• Emilie D., Coumbaras J., Raphael M., Devergne O., Delecluse H. J., Gisselbrecht C., Michiels J. F., Damme J. V., Taga T., Kishimoto T., Crevon M. C., Galanaud P. Interleukin-6 production in high-grade lymphomas: Correlation with the presence of malignant immunoblasts in acquired immunodeficiency syndrome and in human immunodeficiency virus-seronegative patietns. Blood 1992; 80: 498–504
   PubMed Web of Science ®Google Scholar
• Hsu S-M., Xie S-S., Waldron J. A. Functional heterogeneity and pathogenic significance of interleukin-6 in B-cell lymphomas. Am. J. Pathol 1992; 141: 915–923
   PubMed Web of Science ®Google Scholar
• Hsu S-M., Waldron J. A., Fink L., King C., Xie S-S., Mansouri A., Barlogie B. Pathogenic significance of interleukin-6 in angioimmunoblastic lymphadenopathy-type T-cell lymphoma. Hum. Pathol 1993; 24: 126–131
   PubMed Web of Science ®Google Scholar
• Taga T., Hibi M., Hirata Y., Yamasaki K., Yasukawa K., Matsuda T., Hirano T., Kishimoto T. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 1989; 58: 573–581
   PubMed Web of Science ®Google Scholar
• Hibi M., Murakami M., Saito M., Hirano T., Taga T., Kishimoto T. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 1990; 63: 1149–1157
   PubMed Web of Science ®Google Scholar
• Murakami M., Hibi M., Nakagawa N., Nakagawa T., Yasukawa K., Yamanishi K., Taga T., Kishimoto T. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinane. Science 1993; 260: 1808–1810
   PubMed Web of Science ®Google Scholar
• Gearing D. P., Comeau M. R., Friend D. J., Gimpel S. D., Thut C. J., McGourty J., Brasher K. K., King J. A., Gillis S., Mosley B., Ziegler S. F., Cosman D. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science 1992; 255: 1434–1437
   PubMed Web of Science ®Google Scholar
• Ip N. Y., Nye S. H., Boulton T. G., Davis S., Taga T., Li Y., Birren S. J., Yasukawa K., Kishimoto T., Anderson D. J., Stahl N., Yancopoulos G. D. CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal-transducing receptor component gp130. Cell 1992; 69: 1121–1132
   PubMed Web of Science ®Google Scholar
• Taga T., Narazaki M., Yasukawa K., Saito T., Miki D., Hamaguchi M., Davis S., Shoyab M., Yancopoulos G. D., Kishimoto T. Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin-6 signal transduer gp130. Proc. Natl. Acad. Sci. USA 1992; 89: 10998–11001
   PubMed Web of Science ®Google Scholar
• Yin T., Taga T., Tsang M. L., Yasukawa T., Kishimoto T., Yang Y. C. Involvement of interleukin-6 signal transducer gp130 in interleukin-11 -mediated signal transduction. J. Immunol 1993; 151: 2555–2561
   PubMed Web of Science ®Google Scholar
• Akira S., Isshiki H., Sugita T., Tanabe O., Kinoshita S., Nishio Y., Nakajima T., Hirano T., Kishimoto T. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J 1990; 9: 1897–1906
   PubMed Web of Science ®Google Scholar
• Poli V., Mancini F. P., Cortese R. IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP. Cell 1990; 63: 643–653
   PubMed Web of Science ®Google Scholar
• Kinoshita S., Akira S., Kishimoto T. A member of the C/EBP family, NF-IL6β, forms a heterodimer and transcriptionally synergizes with NF-IL6. Proc. Natl. Acad. Sci. USA 1992; 87: 1473–1476
   Web of Science ®Google Scholar
• Akira S., Nishio Y., Inoue M., Wang X-J., Wei S., Matsusaka T., Yoshida K., Sudo T., Naruto M., Kishimoto T. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 1994; 77: 63–71
   PubMed Web of Science ®Google Scholar
• Hirano T., Matsuda T., Nakajima K. Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily. Stem Cells 1994; 12: 262–277
   PubMed Web of Science ®Google Scholar
• Oster W., Cicco N. A., Klein H., Hirano T., Kishimoto T., Lindemann A., Mertelsman R. H., Herrman F. Participation of the cytokine interleukin 6, tumor necrosis factor-alpha, and interleukin I-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control. J. Clin. Invest 1989; 84: 451–457
   PubMed Web of Science ®Google Scholar
• Hoang T., Haman A., Goncalves O., Wong G. G., Clark S. C. Interleukin-6 enhances growth factor-dependent proliferation of the blast cells of acute myeloblastic leukemia. Blood 1988; 72: 823–826
   PubMed Web of Science ®Google Scholar
• Zilberstein A., Ruggieri R., Korn J. H., Revel M. Structure and expression of cDNA and genes for human interferon β2, a distinct species inducible by growth stimulatory cytokines. EMBO J 1986; 5: 1529–1533
   PubMedGoogle Scholar
• van der Schoot C. E., Jansen D., Poorter M., Wester M. R., von dem Borne A. E. G. K., Aarden L. A., van Oers R. H. J. Interleukin-6 and Interleukin-1 production in acute leukemia with monocytoid differentiation. Blood 1989; 74: 2081–2087
   PubMed Web of Science ®Google Scholar
• Beauchemin V., Villeneuve L., Rodriguez-Cimadevilla J. C., Rajotte D., Kenney J. S., Clark S. C., Hoang T. Interleukin-6 production by the blast cells of acute myeloblastic leukemia: regulation by endogenous interleukin-1 and biological implications. J. Cell. Physiol 1991; 148: 353–361
   PubMed Web of Science ®Google Scholar
• Griffin J. D., Rambaldi A., Vellenga E., Young D. C., Ostrapovicz D., Cannistra S. A. Secretion of interleukin 1 by acute myelogenous leukemia cells in vitro induces endothelial cells to secrete colony stimulating factors. Blood 1987; 70: 1218–1221
   PubMed Web of Science ®Google Scholar
• Delwel R., Buitenen C. V., Salem M., Bot F., Gillis S., Kaushansky K., Altrock B., Löwenberg B. Interleukin-1 stimulates proliferation of acute myeloblastic leukemia cells by induction of granulocyte-macrophage colony-stimulating factor release. Blood 1989; 74: 586–593
   PubMed Web of Science ®Google Scholar
• Murohashi I., Tohda S., Suzuki T., Nagata K., Yamashita Y., Nara N. Mechanism of action of interleukin 1 on the progenitors of blast cells in acute myeloblastic leukemia. Exp. Hematol 1990; 18: 133–137
   PubMed Web of Science ®Google Scholar
• Brach M. A., Löwenberg B., Mantovani L., Schwulera U., Merterlsmann R., Herrmann F. Interleukin-6 (IL-6) is a intermediate in IL-1-induced proliferation of leukemic human megakaryoblasts. Blood 1990; 76: 1972–1979
   PubMed Web of Science ®Google Scholar
• Bataille R., Zhang X. G., Wijdenes J., Schved J-F., Klein B. Effects of an anti-interleukin-6 (IL-6) murine monoclonal antibody in a patient with acute monoblastic leukemia. Med. Oncol. Tumour Pharmacother 1993; 10: 185–188
   PubMedGoogle Scholar
• Suzuki T., Morio T., Tohda S., Nataga K., Yamashita Y., Imai Y., Aoki N., Hirashima K., Nara N. Effects of interleukin-6 and granulocyte colony-stimulating factor on the proliferation of leukemic blast progenitors from acute myeloblastic leukemia patients. Jpn. J. Cancer Res 1990; 81: 979–986
   PubMedGoogle Scholar
• Suzuki T., Bessho M., Hirashima K., Tohda S., Nagata K., Imai Y., Nara N. Interleukin-6 reduces the optimal growth in vitro of leukemic blast progenitors from acute myeloblastic leukemia patients. Acata Haematol 1992; 87: 63–68
   PubMed Web of Science ®Google Scholar
• d'Hooghe M. C., Fenaux P., Lantoine D., Loucheux-Lefebvre M., Kerckaert J. P. Expression of the interleukin 6 gene in acute myeloid leukemia and myelodysplastic syndromes: a report on 49 cases. Nouv. Rev. Fr. Hematol 1990; 32: 175–177
   PubMedGoogle Scholar
• Sissolak G., Hoffbrand A. V., Mehta A. B., Ganeshaguru K. Effects of interferon-alpha (IFN) on the expression of interleukin I-beta (IL-1). interleukin 6 (IL-6) granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor -alpha (TNF) in acute myeloid leukemia (AML) blasts. Leukemia 1992; 6: 1155–1160
   PubMed Web of Science ®Google Scholar
• Inoue K., Sugiyama H., Ogawa H., Yamagami T., Azuma T., Oka Y., Miwa H., Kita K., Hiraoka A., Masaoka T., Nasu K., Kyo T., Dohy H., Hara J., Kanamaru A., Kishimoto T. Expression of the interleukin-6 (IL-6). IL-6 receptor, and gp130 genes in acute leukemia. Blood 1994; 84: 2672–2680
   PubMed Web of Science ®Google Scholar
• Lopez M., Maroc N., Kerangueven F., Bardin F., Courcoul M., Lavezzi C., Birg F., Mannoni P. Coexpression of the genes for interleukin 6 and its receptor without apparent involvement in the proliferation of acute myeloid leukemia cells. Exp. Hematol 1991; 19: 797–803
   PubMed Web of Science ®Google Scholar
• Zola H., Siderius N., Flego L., Beckman I., Seshadri R. Cytokine receptor expression in leukaemic cells. Leuk. Res 1994; 18: 347–355
   PubMed Web of Science ®Google Scholar